U.S. markets open in 4 hours 4 minutes

PharmaCielo Ltd. (PCLO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.3600-0.0300 (-2.16%)
At close: 3:59PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.3900
Open1.4100
Bid1.3600 x 0
Ask1.3700 x 0
Day's Range1.3400 - 1.4300
52 Week Range0.4100 - 2.9400
Volume58,611
Avg. Volume191,750
Market Cap198.598M
Beta (5Y Monthly)3.62
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    All
    News
    • PharmaCielo Makes Initial Shipment to Canadian Life Sciences Company
      CNW Group

      PharmaCielo Makes Initial Shipment to Canadian Life Sciences Company

      PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that it has made an initial shipment of CBD Isolate (the "Product") to a Canadian life sciences company that specializes in developing and commercializing proprietary drug-delivery technologies (the "Customer"). The Customer intends to use PharmaCielo's Active Ph

    • PharmaCielo Announces Election of Directors - Welcomes Bill Petron, a Global Operations and Cannabis Veteran, as Chairman of the Board
      CNW Group

      PharmaCielo Announces Election of Directors - Welcomes Bill Petron, a Global Operations and Cannabis Veteran, as Chairman of the Board

      PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that all of the nominees listed in the Management Information Circular dated May 11, 2021, were elected as directors of the Company, as a result of a vote conducted at PharmaCielo's Annual General and Special Meeting, held on June 10, 2021 (the "Meeting"). The re

    • PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2021
      CNW Group

      PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2021

      PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO), (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the first quarter ended March 31, 2021.